Edition:
United Kingdom

Bio Rad Laboratories Inc (BIO.N)

BIO.N on New York Stock Exchange

298.55USD
18 Sep 2018
Change (% chg)

$2.59 (+0.88%)
Prev Close
$295.96
Open
$296.45
Day's High
$299.05
Day's Low
$294.12
Volume
48,032
Avg. Vol
34,905
52-wk High
$345.15
52-wk Low
$215.34

Chart for

About

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a... (more)

Overall

Beta: 0.89
Market Cap(Mil.): $6,701.81
Shares Outstanding(Mil.): 29.58
Dividend: --
Yield (%): --

Financials

  BIO.N Industry Sector
P/E (TTM): 446.19 32.30 32.76
EPS (TTM): 0.51 -- --
ROI: 0.43 13.94 14.61
ROE: 0.56 16.79 16.33

BRIEF-Bio-Rad Q1 Earnings Per Share $21.77

* Q1 EARNINGS PER SHARE VIEW $1.07 -- THOMSON REUTERS I/B/E/S

08 May 2018

BRIEF-Bio Rad Laboratories Says CEO Norman Schwartz's 2017 Total Compensation Was $5.4 Mln Vs $4.9 Mln In 2016

* BIO RAD LABORATORIES INC SAYS CEO NORMAN SCHWARTZ'S 2017 TOTAL COMPENSATION WAS $5.4 MILLION VERSUS $4.9 MILLION IN 2016 – SEC FILING Source text: (https://bit.ly/2KCpD6p) Further company coverage:

04 May 2018

Earnings vs. Estimates